Immediate Impact
1 by Nobel laureates 1 from Science/Nature 105 standout
Citing Papers
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
2024 Standout
Works of Miguel Blas being referenced
The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables
2011
A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Miguel Blas | 849 | 285 | 16 | 168 | 9 | 903 | |
| C Pertusa | 865 | 293 | 6 | 176 | 13 | 917 | |
| Joseph T. Leimert | 849 | 324 | 5 | 172 | 8 | 968 | |
| Pedro Muntañola | 806 | 254 | 3 | 169 | 8 | 844 | |
| J. SALVADOR-BAYARRI | 891 | 304 | 4 | 162 | 16 | 964 | |
| Andreas Boehle | 917 | 190 | 6 | 250 | 15 | 1.0k | |
| Adrian van der Meijden | 708 | 282 | 2 | 114 | 11 | 797 | |
| M. S. Gonzalez | 743 | 223 | 2 | 155 | 8 | 792 | |
| F. Millán‐Rodríguez | 753 | 309 | 57 | 122 | 18 | 998 | |
| W. Meyenburg | 417 | 118 | 11 | 303 | 9 | 804 | |
| Ander Astobieta | 916 | 322 | 144 | 175 | 14 | 1.1k |
All Works
Loading papers...